Publications by authors named "Andrew P Mazar"

76Publications

uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions.

Bone Res 2020 17;8:18. Epub 2020 Apr 17.

1Department of Medicine, McGill University, Montréal, QC H4A3J1 Canada.

View Article and Find Full Text PDF
April 2020

9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer.

Sci Rep 2019 12 27;9(1):19977. Epub 2019 Dec 27.

Department of Urology, Molecular Oncology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.

View Article and Find Full Text PDF
December 2019

Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent.

J Am Chem Soc 2019 04 15;141(16):6453-6457. Epub 2019 Apr 15.

Chemistry of Life Processes Institute , Northwestern University , 2145 Sheridan Road , Evanston , Illinois 60208 , United States.

View Article and Find Full Text PDF
April 2019

Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancer.

Oncol Lett 2018 Nov 21;16(5):6437-6444. Epub 2018 Sep 21.

Chemistry of Life Processes Institute, Northwestern University, Evanston, IL 60208, USA.

View Article and Find Full Text PDF
November 2018

Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models.

Transl Oncol 2017 Aug 30;10(4):669-678. Epub 2017 Jun 30.

Center for Developmental Therapeutics, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2170 Campus Dr, Evanston, IL 60208, USA; Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Searle 8-510, Searle Medical Research Building, 320 E Superior Street, Chicago, IL 60611, USA; Chemistry of Life Processes Institute, Northwestern University, 2170 Campus Dr, Evanston, IL 60208, USA. Electronic address:

View Article and Find Full Text PDF
August 2017

Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation.

Cell Rep 2017 05;19(9):1858-1873

Ken and Ruth Davee Department of Neurology, The Northwestern Brain Tumor Institute, The Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, International Institute for Nanotechnology, Northwestern University, Chicago, IL 60611, USA. Electronic address:

View Article and Find Full Text PDF
May 2017

Targeting melanoma with front-line therapy does not abrogate Nodal-expressing tumor cells.

Lab Invest 2017 02 24;97(2):176-186. Epub 2016 Oct 24.

Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.

View Article and Find Full Text PDF
February 2017

Antibody-based PET of uPA/uPAR signaling with broad applicability for cancer imaging.

Oncotarget 2016 Nov;7(45):73912-73924

Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, Michigan 48109, United States.

View Article and Find Full Text PDF
November 2016

GSK-3 inhibition overcomes chemoresistance in human breast cancer.

Cancer Lett 2016 10 14;380(2):384-92. Epub 2016 Jul 14.

Center for Developmental Therapeutics, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2170 Campus Drive, Evanston, IL 60208, USA; Chemistry of Life Processes Institute, Northwestern University, 2170 Campus Drive, Evanston, IL, 60208, USA; Northwestern Medicine Developmental Therapeutics Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Olson Pavilion, 233 East Superior Street, Chicago, IL 60611, USA; Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Searle Building 8-510, 320 East Superior Street, Chicago, IL 60611, USA. Electronic address:

View Article and Find Full Text PDF
October 2016

Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.

Neuro Oncol 2016 11 1;18(11):1519-1528. Epub 2016 Jul 1.

Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (R.H., A.Z., C.D.J., A.M.S., C.H.); Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (R.H., C.D.J.); Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (A.H.S., S.-Y.C.), Northwestern Brain Tumor Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (R.H., R.R.L., S.G., A.M.S., A.P.M., A.H.S., S.-Y.C., C.H., C.D.J.); Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (R.H., R.R.L., S.G., A.P.M., A.H.S., S.-Y.C., C.H., C.D.J.); Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois (A.P.M., C.D.J.); Department of Pediatrics, Division of Hematology/Oncology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois (R.R.L., S.G.); Department of Neurological Surgery, University of California San Francisco, San Francisco, California (S.M., M.D.P.); Department of Pediatrics, University of California San Francisco, San Francisco, California (S.M.); Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts (D.A.H.-K.); Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota (J.N.S.); Lombardi Cancer Center, Georgetown University, Washington, DC (T.W.).

View Article and Find Full Text PDF
November 2016